Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason F Wiggins

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Infection and Immunity|August 29, 2007
Anthrax protective antigen cleavage and clearance from the blood of mice and ratsMahtab Moayeri, Jason F Wiggins, Stephen H Leppla
Infection and Immunity|January 24, 2006
Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred miceYehoshua Gozes, Mahtab Moayeri, Jason F Wiggins, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Cisplatin inhibition of anthrax lethal toxinMahtab Moayeri, Jason F Wiggins, Robin E Lindeman, et al.
Infection and Immunity|June 23, 2006
Oxidized ATP protection against anthrax lethal toxinMahtab Moayeri, Katherine E Wickliffe, Jason F Wiggins, et al.
Infection and Immunity|June 24, 2005
Endocrine perturbation increases susceptibility of mice to anthrax lethal toxinMahtab Moayeri, Jeanette I Webster, Jason F Wiggins, et al.
Molecular Cancer Therapeutics|July 24, 2014
Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancerChristopher L Daige, Jason F Wiggins, Leslie Priddy, et al.
Molecular and Cellular Biology|May 2, 2006
Dph3, a small protein required for diphthamide biosynthesis, is essential in mouse developmentShihui Liu, Jason F Wiggins, Taduru Sreenath, et al.
Cancer Research|June 24, 2010
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34Jason F Wiggins, Lynnsie Ruffino, Kevin Kelnar, et al.
Infection and Immunity|March 7, 2007
Anthrax edema toxin sensitizes DBA/2J mice to lethal toxinAaron M Firoved, Mahtab Moayeri, Jason F Wiggins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 24, 2011
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in micePhong Trang, Jason F Wiggins, Christopher L Daige, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Infection and Immunity|August 29, 2007
Anthrax protective antigen cleavage and clearance from the blood of mice and ratsMahtab Moayeri, Jason F Wiggins, Stephen H Leppla
Infection and Immunity|January 24, 2006
Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred miceYehoshua Gozes, Mahtab Moayeri, Jason F Wiggins, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Cisplatin inhibition of anthrax lethal toxinMahtab Moayeri, Jason F Wiggins, Robin E Lindeman, et al.
Infection and Immunity|June 23, 2006
Oxidized ATP protection against anthrax lethal toxinMahtab Moayeri, Katherine E Wickliffe, Jason F Wiggins, et al.
Infection and Immunity|June 24, 2005
Endocrine perturbation increases susceptibility of mice to anthrax lethal toxinMahtab Moayeri, Jeanette I Webster, Jason F Wiggins, et al.
Molecular Cancer Therapeutics|July 24, 2014
Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancerChristopher L Daige, Jason F Wiggins, Leslie Priddy, et al.
Molecular and Cellular Biology|May 2, 2006
Dph3, a small protein required for diphthamide biosynthesis, is essential in mouse developmentShihui Liu, Jason F Wiggins, Taduru Sreenath, et al.
Cancer Research|June 24, 2010
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34Jason F Wiggins, Lynnsie Ruffino, Kevin Kelnar, et al.
Infection and Immunity|March 7, 2007
Anthrax edema toxin sensitizes DBA/2J mice to lethal toxinAaron M Firoved, Mahtab Moayeri, Jason F Wiggins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 24, 2011
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in micePhong Trang, Jason F Wiggins, Christopher L Daige, et al.
Pageof 2